Just a moment...
Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
Step 1 – Issue Identification & Review
The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.
• Review the issues identified by the AI
• Add, edit, remove, or refine issues as required
Step 2 – Draft Generation
Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.
• Relevant statutory provisions
• Judicial precedents and Supreme Court, High Court and other citations
• Issue-wise legal analysis
• Practical arguments and supporting content
• Professionally structured draft ready for further review. 
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether medicinal formulations containing less than 135 mg of Dextropropoxyphene could be classified as a narcotic drug under Section 2(h) of the Medicinal and Toilet Preparations (Excise Duties) Act, 1955, and subjected to duty under that Act.
Analysis: The relevant notification excluded preparations for oral use containing not more than 135 milligrams of Dextropropoxyphene base per dosage unit. The formulations in question contained only 65 mg of Dextropropoxyphene. On a plain reading of the notification, such preparations fell within the exclusion and could not be treated as narcotic drugs or narcotics for the purpose of the Act. The contrary view adopted in the impugned orders was inconsistent with the applicable notification and the earlier decisions relied upon.
Conclusion: The formulations containing less than 135 mg of Dextropropoxyphene were not classifiable as narcotic drugs under the Act and the demand of excise duty could not stand.
Final Conclusion: The petition succeeded, the impugned orders were set aside, and the petitioners were granted consequential relief.
Ratio Decidendi: Where a statutory notification expressly excludes medicinal preparations containing not more than the stipulated quantity of a specified substance, preparations falling within that threshold cannot be treated as narcotic drugs for levy purposes under the Act.